FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma

被引:23
作者
Cooke, Mariana [1 ,2 ]
Kreider-Letterman, Gabriel [3 ]
Baker, Martin J. [1 ]
Zhang, Suli [1 ]
Sullivan, Neil T. [4 ]
Eruslanov, Evgeniy [4 ]
Abba, Martin C. [5 ]
Goicoechea, Silvia M. [3 ]
Garcia-Mata, Rafael [3 ]
Kazanietz, Marcelo G. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA
[2] Einstein Med Ctr Philadelphia, Dept Med, Philadelphia, PA 19141 USA
[3] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA
[4] Univ Penn, Div Thorac Surg, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, RA-1900 La Plata, Argentina
来源
CELL REPORTS | 2021年 / 37卷 / 05期
关键词
GROWTH-FACTOR RECEPTOR; TERMINAL SH3 DOMAIN; THERAPEUTIC TARGET; POOR-PROGNOSIS; CANCER; ACTIVATION; RAC; GAB1; PROTEINS; DYNAMICS;
D O I
10.1016/j.celrep.2021.109905
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Despite the undisputable role of the small GTPase Rac1 in the regulation of actin cytoskeleton reorganization, the Rac guanine-nucleotide exchange factors (Rac-GEFs) involved in Rac1-mediated motility and invasion in human lung adenocarcinoma cells remain largely unknown. Here, we identify FARP1, ARHGEF39, and TIAM2 as essential Rac-GEFs responsible for Rac1-mediated lung cancer cell migration upon EGFR and c-Met activation. Noteworthily, these Rac-GEFs operate in a non-redundant manner by controlling distinctive aspects of ruffle dynamics formation. Mechanistic analysis reveals a leading role of the AXL-Gab1-PI3K axis in conferring pro-motility traits downstream of EGFR. Along with the positive association between the overexpression of Rac-GEFs and poor lung adenocarcinoma patient survival, we show that FARP1 and ARHGEF39 are upregulated in EpCam(+) cells sorted from primary human lung adenocarcinomas. Overall, our study reveals fundamental insights into the complex intricacies underlying Rac-GEF-mediated cancer cell motility signaling, hence underscoring promising targets for metastatic lung cancer therapy.
引用
收藏
页数:24
相关论文
共 76 条
  • [1] The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor Nck
    Abella, Jasmine V.
    Vaillancourt, Richard
    Frigault, Melanie M.
    Ponzo, Marisa G.
    Zuo, Dongmei
    Sangwan, Veena
    Larose, Louise
    Park, Morag
    [J]. JOURNAL OF CELL SCIENCE, 2010, 123 (08) : 1306 - 1319
  • [2] Axl Phosphorylates Elmo Scaffold Proteins To Promote Rac Activation and Cell Invasion
    Abu-Thuraia, Afnan
    Gauthier, Rosemarie
    Chidiac, Rony
    Fukui, Yoshinori
    Screaton, Robert A.
    Gratton, Jean-Philippe
    Cote, Jean-Francois
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2015, 35 (01) : 76 - 87
  • [3] A CDC42-centered signaling unit is a dominant positive regulator of endothelial integrity
    Amado-Azevedo, J.
    Reinhard, N. R.
    van Bezu, J.
    de Menezes, R. X.
    van Beusechem, V. W.
    Amerongen, G. P. van Nieuw
    van Hinsbergh, V. W. M.
    Hordijk, P. L.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [4] Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms
    Bagci, Halil
    Sriskandarajah, Neera
    Robert, Amelie
    Boulais, Jonathan
    Elkholi, Islam E.
    Tran, Viviane
    Lin, Zhen-Yuan
    Thibault, Marie-Pier
    Dube, Nadia
    Faubert, Denis
    Hipfner, David R.
    Gingras, Anne-Claude
    Cote, Jean-Francois
    [J]. NATURE CELL BIOLOGY, 2020, 22 (01) : 120 - +
  • [5] Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer
    Bahcall, Magda
    Awad, Mark M.
    Sholl, Lynette M.
    Wilson, Frederick H.
    Xu, Man
    Wang, Stephen
    Palakurthi, Sangeetha
    Choi, Jihyun
    Ivanova, Elena V.
    Leonardi, Giulia C.
    Ulrich, Bryan C.
    Paweletz, Cloud P.
    Kirschmeier, Paul T.
    Watanabe, Masayuki
    Baba, Hideo
    Nishino, Mizuki
    Nagy, Rebecca J.
    Lanman, Richard B.
    Capelletti, Marzia
    Chambers, Emily S.
    Redig, Amanda J.
    VanderLaan, Paul A.
    Costa, Daniel B.
    Imamura, Yu
    Janne, Pasi A.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (23) : 5963 - 5976
  • [6] Evaluation of active Rac1 levels in cancer cells: A case of misleading conclusions from immunofluorescence analysis
    Baker, Martin J.
    Cooke, Mariana
    Kreider-Letterman, Gabriel
    Garcia-Mata, Rafael
    Janmey, Paul A.
    Kazanietz, Marcelo G.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (40) : 13698 - 13710
  • [7] RHO GTPases in cancer: known facts, open questions, and therapeutic challenges
    Bustelo, Xose R.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 741 - 760
  • [8] Non-Small Cell Lung Carcinoma Cell Motility, Rac Activation and Metastatic Dissemination Are Mediated by Protein Kinase C Epsilon
    Caino, M. Cecilia
    Lopez-Haber, Cynthia
    Kissil, Joseph L.
    Kazanietz, Marcelo G.
    [J]. PLOS ONE, 2012, 7 (02):
  • [9] RAC1 as a Therapeutic Target in Malignant Melanoma
    Cannon, Alexa C.
    Uribe-Alvarez, Cristina
    Chernoff, Jonathan
    [J]. TRENDS IN CANCER, 2020, 6 (06): : 478 - 488
  • [10] The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic
    Casado-Medrano, Victoria
    Baker, Martin J.
    Lopez-Haber, Cynthia
    Cooke, Mariana
    Wang, Shaofei
    Caloca, Maria J.
    Kazanietz, Marcelo G.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 1003 - 1012